Abstract:N-cadherin serves as an important oncobiomarker of epithelial-to-mesenchymal transition (EMT) progression, which identifies invasion and metastasis of malignant tumor cells. Although many efforts have been devoted to quantitative detection of N-cadherin, efforts to analyzing the protein of interest at intact cellular levels are scarce. Herein, a metal cluster-based electrochemical biosensing system is developed to determine the expressing levels of N-cadherin during the EMT process of tumor cells. To be specific, a peptide with a unique sequence and function is designed as a reductant and an anchor to synthesize metal clusters in a precise manner. Consequently, peptide-modified metal clusters possess N-cadherin-targeting, photoluminescence, and electrocatalytic properties. Especially, the redox-active metal clusters function as both an electron-transfer mediator and an electronic conductor for enhanced electrochemical sensing. These favorable features enable them as a rapid, sensitive, and reliable whole-cell biosensor, which integrates the fluorescence and electrochemical signals. This cytosensor can accurately quantify the expression levels of N-cadherin on at least 5000 tumor cells. Further, the current signals of model cancer cells gradually increase with EMT progression, indicating tumor cell-type evolution. Our study represents the advanced bioprobe and analytical methods for accurate quantitation of a biomarker to identify tumor progression.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acssensors.1c00339?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acssensors.1c00339</a>.The formula of quantitative calculation, the stability of AuCs, optimization of conditions of cells labeled with AuCs, optimization of electrochemical test conditions, the influence of pH changes on the current signal, the characterization of the surface morphology and the structure of the modified electrode, the effect of pure cells on the current signal, and quantitative analysis of N-cadherin in CaSki cells with lower N-cadherin levels (<a class="ext-link" href="/doi/suppl/10.1021/acssensors.1c00339/suppl_file/se1c00339_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Mechanical Characterization of Cancer Cells During TGF-β1-induced Epithelial-Mesenchymal Transition Using an Electrodeformation-Based Microchip

In Situ Continuously Monitoring of Cancer Cell Invasion Process Based on Impedance Sensing

An Electrodeformation-based Biomechanical Chip for Quantifying Global Viscoelasticity of Cancer Cells Regulated by Cell Cycle.

Micro-electrode cell-based biosensor using electrochemical impedance spectroscopy for cancer research

Micro Chip with Nanostructured Membranes for Cell Morphology Monitoring

Microfluidic Analysis for Separating and Measuring the Deformability of Cancer Cell Subpopulations

Monitoring Partial EMT Dynamics through Cell Mechanics Using Scanning Ion Conductance Microscopy

Microfluidic Device Featuring Micro-Constrained Channels for Multi-Parametric Assessment of Cellular Biomechanics and High-Precision Mechanical Phenotyping of Gastric Cells

Monitoring of TGF-β 1-Induced Human Lung Adenocarcinoma A549 Cells Epithelial-Mesenchymal Transformation Process by Measuring Cell Adhesion Force with a Microfluidic Device

Tracking epithelial-mesenchymal transition in breast cancer cells based on a multiplex electrochemical immunosensor

Micro Channel for Analyzing Mechanical Adaption of Cancer Cell.

Epithelial-Mesenchymal Transition of Cancer Cells on Micropillar Arrays

Cell Characterization by Sequential Mechanical Stress in Micro Channel

Mechanotactic Activation of TGF‐β by PEDOT Artificial Microenvironments Triggers Epithelial to Mesenchymal Transition

Effects of Cell Shape and Nucleus Shape on Epithelial-Mesenchymal Transition Revealed Using Chimeric Micropatterns

Deep-Learning-Based Nanomechanical Vibration for Rapid and Label-Free Assay of Epithelial Mesenchymal Transition.

Optical Deformability as an Inherent Cell Marker for Testing Malignant Transformation and Metastatic Competence

Multiplex Sensing of Biomarkers on the Cancer Cell Surface by an Epithelial-Mesenchymal Transition (EMT) Sensing Panel Enables Precise Differentiating of Cancer Cells at Various EMT Stages

On-chip Integrated Optical Stretching and Electrorotation Enabling Single-Cell Biophysical Analysis

Metal Cluster-Based Electrochemical Biosensing System for Detecting Epithelial-to-Mesenchymal Transition

Mechanomics Biomarker for Cancer Cells Unidentifiable through Morphology and Elastic Modulus